Service Providers
Name of Company
CC&I Research Co., Ltd.
Address
Suite 1501, 21 Teheran-ro 52-gil, Gangnam-gu, Seoul
Key Services
  • Clinical CRO
Homepage(English)
http://www.ccnires.com/
Sales(end of 2024)
NR
Human Resources Status
25
Number of audit of Regulatory agency(ex FDA/EMA, etc.)
ISO 9001
Not Provided
Status of Additional Certifications
CC&I Research holds patents for a COPD acute exacerbation prediction algorithm in the U.S. and China.
Key Strengths

The company combines a team of experienced clinicians, medical advisors, and highly qualified Ph.D. and master’s-level professionals in medical writing and statistics to manage projects for leading domestic pharmaceutical companies. (1) End-to-End Clinical Solutions - From study design to completion across various indications, including SIT, IIT, Phase I–IV trials, PMS, OS, registry studies, limited medical technology research, and clinical consulting. (2) Health Economics & Outcomes Research - Systematic literature reviews, meta-analyses, and big data analysis of claims from the Health Insurance Review & Assessment Service and National Health Insurance Service. (3) Clinical Informatics & Data Analysis - Integrated biostatistics and big data services forming CC&I Research’s next-generation strategic capabilities.

Introduction Materials (Upload attachment)
-
Services Provided by Clinical CROs
Clinical Operation
Provided
Medical Writing
Provided
Statistics
Provided
Data Management
Provided
Regulatory Affairs
Provided
Pharmacovigilance
Provided
Vendor Management
Provided
Consulting
Provided
Feasibility Service
Provided
Medical Monitoring
Not Provided
Training and Education
Not Provided
IT Solution
Not Provided
CDISC data service
Not Provided
Project Management
Provided
Compliance Certification Status for Domestic and International Data Protection Regulations
Data Protection Regulation_GDPR
Not Provided
Data Protection Regulation_21CFR11
Not Provided
Data Protection Regulation_others